Letter: ACE2, IBD and COVID-19—why IBD patients may be at reduced risk of COVID-19

Ralley E. Prentice; Doug Tjandra; Mayur Garg; John S. Lubel; Spiros Fourlanos; Doug Johnson; Aysha Al-Ani; Britt Christensen

doi:10.1111/apt.16063

Letter: ACE2, IBD and COVID-19—why IBD patients may be at reduced risk of COVID-19

Ralley E. Prentice, Doug Tjandra, Mayur Garg, John S. Lubel, Spiros Fourlanos, Doug Johnson, Aysha Al-Ani, Britt Christensen

Gastroenterology

Research output: Contribution to journal › Letter › Other › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	1422-1423
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	52
Issue number	8
DOIs	https://doi.org/10.1111/apt.16063
Publication status	Published - 1 Oct 2020

Access to Document

10.1111/apt.16063

Cite this

@article{3f435c43ab074f0f9faa8984c4efd621,

title = "Letter: ACE2, IBD and COVID-19—why IBD patients may be at reduced risk of COVID-19",

author = "Prentice, {Ralley E.} and Doug Tjandra and Mayur Garg and Lubel, {John S.} and Spiros Fourlanos and Doug Johnson and Aysha Al-Ani and Britt Christensen",

year = "2020",

month = oct,

day = "1",

doi = "10.1111/apt.16063",

language = "English",

volume = "52",

pages = "1422--1423",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell",

number = "8",

}

TY - JOUR

T1 - Letter

T2 - ACE2, IBD and COVID-19—why IBD patients may be at reduced risk of COVID-19

AU - Prentice, Ralley E.

AU - Tjandra, Doug

AU - Garg, Mayur

AU - Lubel, John S.

AU - Fourlanos, Spiros

AU - Johnson, Doug

AU - Al-Ani, Aysha

AU - Christensen, Britt

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85091102379&partnerID=8YFLogxK

U2 - 10.1111/apt.16063

DO - 10.1111/apt.16063

M3 - Letter

AN - SCOPUS:85091102379

SN - 0269-2813

VL - 52

SP - 1422

EP - 1423

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 8

ER -

Letter: ACE2, IBD and COVID-19—why IBD patients may be at reduced risk of COVID-19

Access to Document

Other files and links

Cite this